Pre-ablation prehabilitation to improve recovery after atrial fibrillation ablation
Official title: Impact of Pre-Ablation Prehabilitation on Clinical Outcomes and Cardiorespiratory Fitness in Patients With Atrial Fibrillation: A Randomized Controlled Trial
Run by Nanjing Medical University · NCT07270757 · Data updated 2026-11-12
A 4-week supervised program of exercise and psychological education will be tested in people with atrial fibrillation scheduled for their first catheter ablation to see if it improves post-procedure fitness and clinical outcomes compared with usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Nanjing Medical University Academic / other |
| Locations | 1 site (Nanjing, Please Select) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | February 2026 |
| Study ends | March 2026 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT07270757 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–70 years old scheduled for their first AF ablation with NYHA class I–II and LVEF ≥50% are ideal candidates.
✕Probably not a fit
Patients with significant structural heart disease, contraindications to exercise or CPET, cognitive impairment, prior AF ablation, or LVEF below 50% are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patients scheduled for first-time catheter ablation for atrial fibrillation will be offered a physician-supervised 4-week prehabilitation program combining exercise training and psychological education or usual care prior to their procedure. Cardiorespiratory fitness will be measured with cardiopulmonary exercise testing and clinical outcomes will be tracked after ablation to compare recovery between groups. The trial targets improvements in objective functional capacity and patient-reported recovery during the early post-procedural period. The protocol addresses perioperative fear of movement and the early blanking-period arrhythmia burden as barriers to rehabilitation.
Why it matters
Potential benefit: If successful, the program could help patients recover better cardiorespiratory fitness and quality of life after AF ablation and shorten functional recovery time.
How similar studies have gone: Cardiac rehabilitation and prehabilitation have improved outcomes after other cardiac procedures, but pre-ablation prehabilitation for AF is relatively novel with limited direct evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18-70 years 2. Scheduled for first AF ablation 3. NYHA class I-II 4. LVEF ≥ 50% Exclusion Criteria: 1. Significant structural heart disease (e.g., severe valvular disease) 2. Contraindications to CPET or exercise training 3. Cognitive impairment preventing cooperation
Where it's running
-
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Please Select, China Recruiting
Study contacts
- Study coordinator: Kexin Wang
- Email: 840507356@qq.com
- Phone: +8618018223427
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
-
AI-based cardiac analysis using 12-lead and 1-lead ECG
A clinician-facing pilot test to see if SmartECG-EF helps evaluate heart function using both 12-lead and single-lead ECGs in adults with heart conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.